RxSight (RXST) Asset Writedowns and Impairment (2020 - 2026)
RxSight posted quarterly Asset Writedowns and Impairment of $60000.0 for Q1 2026, up 93.55% year-on-year from $31000.0 in Q1 2025, and down 90.26% on a QoQ basis from $616000.0 in Q4 2025.
RxSight (RXST) has 7 years of Asset Writedowns and Impairment data on file, last reported at $60000.0 in Q1 2026.
- For the quarter ending Q1 2026, Asset Writedowns and Impairment rose 93.55% year-over-year to $60000.0; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (up 505.25% YoY), and the FY2025 full-year result was $1.9 million, up 378.22% from the prior year.
- Asset Writedowns and Impairment for Q1 2026 stood at $60000.0, down from $616000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $1.2 million in Q2 2025 and bottomed at -$1000.0 in Q3 2023.
- The 5-year median for Asset Writedowns and Impairment is $71000.0 (2024), against an average of $194823.5.
- The widest annual swing landed in 2023, when Asset Writedowns and Impairment tumbled 100.3%; it then surged 16700.0% in 2024.
- A 5-year view of Asset Writedowns and Impairment shows it stood at $298000.0 in 2022, then sank by 49.33% to $151000.0 in 2023, then sank by 52.98% to $71000.0 in 2024, then surged by 767.61% to $616000.0 in 2025, then sank by 90.26% to $60000.0 in 2026.
- The last three Asset Writedowns and Impairment figures came in at $60000.0 (Q1 2026), $616000.0 (Q4 2025), and $66000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RxSight | 215.82 Mn | -2.06 Mn | 23.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60,000.00 |
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 616,000.00 |
| Dec 31, 2025 | 616,000.00 |
| Sep 30, 2025 | 66,000.00 |
| Sep 30, 2025 | 66,000.00 |
| Jun 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 31,000.00 |
| Mar 31, 2025 | 31,000.00 |
| Dec 31, 2024 | 71,000.00 |
| Dec 31, 2024 | 71,000.00 |
| Sep 30, 2024 | 166,000.00 |
| Sep 30, 2024 | 166,000.00 |
| Jun 30, 2024 | 56,000.00 |
| Jun 30, 2024 | 56,000.00 |
| Mar 31, 2024 | 111,000.00 |
| Mar 31, 2024 | 111,000.00 |
| Dec 31, 2023 | 151,000.00 |
| Dec 31, 2023 | 151,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Mar 31, 2023 | 10,000.00 |
| Dec 31, 2022 | 298,000.00 |
| Dec 31, 2022 | 298,000.00 |
| Sep 30, 2022 | 334,000.00 |
| Sep 30, 2022 | 334,000.00 |
| Jun 30, 2022 | 47,000.00 |
| Jun 30, 2022 | 47,000.00 |
| Mar 31, 2022 | 73,000.00 |
| Mar 31, 2022 | 73,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Dec 31, 2021 | 10,000.00 |
| Sep 30, 2021 | 608,000.00 |
| Sep 30, 2021 | 608,000.00 |
| Jun 30, 2021 | 1.76 Mn |
| Jun 30, 2021 | 1.76 Mn |
| Mar 31, 2021 | -7,000.00 |
| Mar 31, 2021 | -7,000.00 |
| Dec 31, 2020 | 210,000.00 |
| Dec 31, 2020 | 210,000.00 |
| Sep 30, 2020 | -19,000.00 |
| Sep 30, 2020 | -19,000.00 |